Stocks and Investing Stocks and Investing
Tue, November 15, 2022
[ 12:00 AM ] - United States, WOPRAI
Corey Tarlowe Maintained (TGT) at Strong Buy and Held Target at $185 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Bora Lee Maintained (CCOI) at Buy with Decreased Target to $61 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brandon Rolle Downgraded (BC) to Hold and Held Target at $82 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Bedell Maintained (BEN) at Hold with Increased Target to $26 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Robyn Karnauskas Maintained (BIIB) at Strong Buy with Increased Target to $350 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gary Nachman Maintained (SRRK) at Buy with Decreased Target to $32 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jeff Van Sinderen Initiated (STGW) at Strong Buy and Held Target at $13 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Alicia Yap Maintained (SOHU) at Strong Buy with Decreased Target to $21 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jade Rahmani Maintained (DBRG) at Hold with Decreased Target to $17 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Molloy Maintained (SLS) at Strong Buy with Decreased Target to $8 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Arvind Ramnani Downgraded (TWKS) to Hold and Decreased Target to $9.5 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Daniel Perlin Maintained (TWKS) at Buy with Decreased Target to $14 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Kevin Mcveigh Maintained (TWKS) at Hold with Decreased Target to $13 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Bedell Maintained (TW) at Hold with Increased Target to $62 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Zach Cummings Downgraded (TLS) to Hold and Increased Target to $5 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ivan Feinseth Maintained (TMUS) at Strong Buy with Increased Target to $202 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Patrick Scholes Maintained (TNL) at Strong Buy with Decreased Target to $60 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Larry Biegelsen Upgraded (TNDM) to Hold and Held Target at $43 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Joseph Parkhill Maintained (TPG) at Strong Buy with Increased Target to $48 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Bedell Maintained (TPG) at Strong Buy with Increased Target to $49 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Bedell Maintained (TROW) at Hold with Increased Target to $123 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Arun Jayaram Maintained (TS) at Buy with Increased Target to $50 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Kenneth Zaslow Maintained (TSN) at Hold with Decreased Target to $75 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ken Goldman Maintained (TSN) at Hold with Decreased Target to $70 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Patrick Scholes Maintained (VAC) at Strong Buy with Increased Target to $205 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ben Piggott Maintained (USEG) at Strong Buy with Decreased Target to $4 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Stanley Elliott Maintained (URI) at Strong Buy and Held Target at $425 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ross Gilardi Maintained (URI) at Strong Buy with Increased Target to $415 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Fatima Boolani Maintained (AVPT) at Hold with Increased Target to $5 on, Nov 15th, 2022
[ 12:00 AM ] - United States, WOPRAI
Vikram Purohit Maintained (ASND) at Buy with Increased Target to $148 on, Nov 15th, 2022

Vikram Purohit Maintained (ASND) at Buy with Increased Target to $148 on, Nov 15th, 2022


Published on 2024-10-28 00:10:42 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $146 to $148 on, Nov 15th, 2022.

Vikram has made no other calls on ASND in the last 4 months.



There are 8 other peers that have a rating on ASND. Out of the 8 peers that are also analyzing ASND, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Vikram

  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $164 on, Monday, November 14th, 2022
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $148 on, Monday, November 14th, 2022
  • Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $169 on, Monday, November 7th, 2022
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $163 on, Thursday, November 3rd, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Thursday, November 3rd, 2022
  • Paul Choi of "Goldman Sachs" Initiated at Strong Buy and Held Target at $174 on, Thursday, October 20th, 2022
  • Caroline Palomeque of "Berenberg" Initiated at Strong Buy and Held Target at $166 on, Tuesday, August 30th, 2022
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $144 on, Thursday, August 11th, 2022

Contributing Sources